Fundz

Corner Therapeutics reported raising $58.5 Million in an initial SEC Form D filing, from an offering of $50.9 Million

PRIVATEApr 23, 2024Late filing, first sale May 31, 2023

Amount Raised

$58.5 Million

$58.5 Million sold, per SEC Form D (first sale May 31, 2023)

Round Type

Venture

WatertownBiotechnologyHealth CareTherapeuticsresearch

Quick answer

Corner Therapeutics raised $58.5 Million in a funding round, dated May 31, 2023. Corner Therapeutics is based in Watertown, Massachusetts, United States.

How much did Corner Therapeutics raise?
Corner Therapeutics raised $58.5 Million in a funding round on May 31, 2023.
What does Corner Therapeutics do?
Corner is pioneering a new class of immunotherapies.
Where is Corner Therapeutics based and how big is it?
Corner Therapeutics is based in Watertown, Massachusetts, United States. Fundz records about 35 employees.
Who are the decision-makers at Corner Therapeutics?
Fundz holds 2 contacts at Corner Therapeutics, including the Chief Financial Officer, Chief Business Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and research around the same time

Companies in the same sectors as Corner Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Legend Biotech raised $200M on April 19, 2023.
  • Tenpoint Therapeutics raised $70M (Series A) on July 12, 2023.
  • Smartlens raised $6.1M (Series A) on July 11, 2023.
  • TolerogenixX raised $13M (Series A) on July 6, 2023.
  • MapLight Therapeutics raised $50M on July 5, 2023.
  • Actym Therapeutics raised $11M on June 28, 2023.

Who to call at Corner Therapeutics, and when

A new round usually means Corner Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Corner Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Corner Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Corner Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Corner Therapeutics

Location

498 N Beacon St

Watertown, Massachusetts, United States

About

Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust, rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Corner Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsNicholas S., Chief Financial Officer, Chief Business… hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Corner Therapeutics's next move

See what Strategic adds

Corner Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.